Literature DB >> 11739980

Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case-control study.

C A Molina1, J Montaner, S Abilleira, J F Arenillas, M Ribó, R Huertas, F Romero, J Alvarez-Sabín.   

Abstract

BACKGROUND AND
PURPOSE: The relationship between arterial recanalization, infarct size, and outcome in patients treated with intravenous thrombolytics remains unclear. Therefore, we aimed to determine the time course of recombinant tissue plasminogen activator (rtPA)-induced recanalization in patients with cardioembolic stroke treated <3 hours from symptom onset and to investigate the relationship between arterial recanalization, infarct volume, and outcome.
METHODS: We prospectively studied 72 patients with an acute cardioembolic stroke in the middle cerebral artery territory: 24 treated with rtPA at <3 hours and 48 matched controls. Serial transcranial Doppler examinations were performed on admission and at 6,12, 24, and 48 hours. Infarct volume was measured by use of CT at day 5 to 7. Modified Rankin Scale score was used to assess outcome at 3 months.
RESULTS: Rate of 6-hour recanalization was higher (P<0.001) in the rtPA group (66%) than in the control group (15%). Five (20.8%) rtPA patients and 15 (31.2%) controls recanalized between 6 and 12 hours, and 2 (8.3%) patients and 12 (25%) controls between 12 and 48 hours, respectively. At 48 hours, 75% of rtPA patients and 27% of controls had improved (P<0.001). Infarct volume was 50.2+/-40.3 cm(3) in rtPA patients and 124.8+/-81.6 cm(3) in controls (P<0.001). Moreover, infarct volume was associated strongly (P<0.001) with duration of middle cerebral artery occlusion. At 3 months, 14 (58%) rtPA patients and 11 (23%) controls (P=0.037) became functionally independent (modified Rankin Scale score </=2). A close relationship (P=0.002) existed between modified Rankin Scale score at 3 months and time to reperfusion. In addition, clinical outcome was associated strongly (P=0.001) with degree of 6-hour recanalization. Logistic regression analysis identified National Institutes of Health Stroke Scale score <17 (odds ratio 12.1, 95% confidence interval 2.8 to 68, P=0.001) and early recanalization (odds ratio 23.4, 95% confidence interval 5.4 to 96, P=0.001) as independent predictors of functional independence at 3 months.
CONCLUSIONS: Intravenous rtPA is associated with early recanalization, which leads to lower infarct size and better clinical outcome. Early recanalization is a powerful independent predictor of functional independence at 3 months.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739980     DOI: 10.1161/hs1201.99821

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  21 in total

1.  Is mechanical clot removal or disruption a cost-effective treatment for acute stroke?

Authors:  M N Nguyen-Huynh; S C Johnston
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-27       Impact factor: 3.825

2.  Simultaneous functional photoacoustic microscopy and electrocorticography reveal the impact of rtPA on dynamic neurovascular functions after cerebral ischemia.

Authors:  Aishwarya Bandla; Lun-De Liao; Su Jing Chan; Ji Min Ling; Yu-Hang Liu; Yen-Yu Ian Shih; Han-Chi Pan; Peter Tsun-Hon Wong; Hsin-Yi Lai; Nicolas Kon Kam King; You-Yin Chen; Wai Hoe Ng; Nitish V Thakor
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-07       Impact factor: 6.200

3.  Reperfusion therapy for acute stroke improves outcome by decreasing neuroinflammation.

Authors:  Joan Montaner; David Salat; Teresa García-Berrocoso; Carlos A Molina; Pilar Chacón; Marc Ribó; José Alvarez-Sabín; Anna Rosell
Journal:  Transl Stroke Res       Date:  2010-08-28       Impact factor: 6.829

4.  Good clinical outcome after ischemic stroke with successful revascularization is time-dependent.

Authors:  P Khatri; T Abruzzo; S D Yeatts; C Nichols; J P Broderick; T A Tomsick
Journal:  Neurology       Date:  2009-09-29       Impact factor: 9.910

5.  A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial.

Authors:  S M Zinkstok; M Vermeulen; J Stam; R J de Haan; Y B Roos
Journal:  Trials       Date:  2010-05-12       Impact factor: 2.279

6.  Endovascular treatment outcomes using the Stroke Triage Education, Procedure Standardization, and Technology (STEPS-T) program.

Authors:  Ameer E Hassan; Christina Sanchez; Angela N Johnson
Journal:  Interv Neuroradiol       Date:  2017-11-09       Impact factor: 1.610

7.  Long-term outcomes of post-thrombolytic intracerebral hemorrhage in ischemic stroke patients.

Authors:  Kiersten E Norby; Farhan Siddiq; Malik M Adil; Saqib A Chaudhry; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

8.  Role of recanalization in acute stroke outcome: rationale for a CT angiogram-based "benefit of recanalization" model.

Authors:  E S Rosenthal; L H Schwamm; L Roccatagliata; S B Coutts; A M Demchuk; P W Schaefer; R G Gonzalez; M D Hill; E F Halpern; M H Lev
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-03       Impact factor: 3.825

Review 9.  Alteplase: a review of its use in the management of acute ischaemic stroke.

Authors:  Sohita Dhillon
Journal:  CNS Drugs       Date:  2012-10-01       Impact factor: 5.749

Review 10.  Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy.

Authors:  Yinghua Jiang; Ning Liu; Jinrui Han; Yadan Li; Pierce Spencer; Samuel J Vodovoz; Ming-Ming Ning; Gregory Bix; Prasad V G Katakam; Aaron S Dumont; Xiaoying Wang
Journal:  Transl Stroke Res       Date:  2020-11-02       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.